A detailed history of Values First Advisors, Inc. transactions in Exscientia PLC stock. As of the latest transaction made, Values First Advisors, Inc. holds 62,236 shares of EXAI stock, worth $357,857. This represents 0.21% of its overall portfolio holdings.

Number of Shares
62,236
Previous 55,958 11.22%
Holding current value
$357,857
Previous $358,000 0.84%
% of portfolio
0.21%
Previous 0.22%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$5.3 - $7.51 $33,273 - $47,147
6,278 Added 11.22%
62,236 $355,000
Q4 2023

Jan 18, 2024

BUY
$4.35 - $6.88 $22,141 - $35,019
5,090 Added 10.01%
55,958 $358,000
Q3 2023

Nov 08, 2023

SELL
$4.52 - $8.9 $962 - $1,895
-213 Reduced 0.42%
50,868 $229,000
Q2 2023

Aug 02, 2023

BUY
$4.79 - $8.3 $75,001 - $129,961
15,658 Added 44.2%
51,081 $302,000
Q1 2023

May 15, 2023

BUY
$5.3 - $10.93 $187,741 - $387,173
35,423 New
35,423 $187,000

Others Institutions Holding EXAI

About Exscientia plc


  • Ticker EXAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,461,000
  • Market Cap $704M
  • Description
  • Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...
More about EXAI
Track This Portfolio

Track Values First Advisors, Inc. Portfolio

Follow Values First Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Values First Advisors, Inc. with notifications on news.